Skip to main content
OpenTrials

Clinical trial condition

Sarcoma, Synovial

Explore clinical trials studying Sarcoma, Synovial. Study availability and eligibility vary by location and protocol.

98 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Sarcoma, Synovial trial results

Completed

A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study

NCT02875548

Conditions
Adenoma, Advanced Solid Tumors, Diffuse Large B-Cell Lymphoma (DLBCL), +24 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • California Cancer Associates For Research And Excellence, cCARE Santa Fe, California, United States
  • Hematology Oncology Associates of the Treasure Coast - Port St. Lucie Port Saint Lucie, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 34 locations
View Trial Details
Completed

A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma

NCT02601950

Conditions
Any Solid Tumor With an EZH2 GOF Mutation, Atypical Teratoid Rhabdoid Tumors (ATRT), Epithelioid Sarcoma, +14 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
View all 32 locations
View Trial Details
Completed

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

NCT04537715

Conditions
Adenoma, Advanced Malignancies, All Malignancies, +32 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. (cCARE) Encinitas, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Northwestern University-Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
View Trial Details
Completed

Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma

NCT03250325

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, +4 more
Locations
  • Sapporo Medical University Hospital Sapporo, Hokkaido, Japan
  • Mie University Hospital Tsu, Mie-ken, Japan
  • National Hospital Organization Osaka National Hospital Osaka, Japan
  • National Cancer Center Hospital Chuo-ku, Tokyo, Japan
View Trial Details
Completed

EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma

NCT02601937

Conditions
INI1-negative Tumors, Malignant Rhabdoid Tumor of Ovary, Neoplasms, +9 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of California San Francisco - Benioff Children's Hospital San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 35 locations
View Trial Details
Completed

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

NCT03277924

Conditions
Bone Diseases, Bone Neoplasms, Bone Sarcoma, +27 more
Locations
  • Istituto Ortopedico Rizzoli Bologna, Italy
  • Candiolo Cancer Institute - FPO, IRCCS Candiolo, Italy
  • Istituto Nazionale dei Tumori Milan, Italy
  • Hospital Universitario Fundación Jiménez Díaz Madrid, Spain
View all 13 locations
View Trial Details
Completed

Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

NCT03063632

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +33 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details

Related conditions